Patients were randomized to receive intense immunosuppression ( mobilization with cyclophosphamide and filgrastim , conditioning with carmustine , cytosine-arabinoside , etoposide , melphalan , and anti-thymocyte globulin ) followed by AHSCT or MTX 20 mg every month for 6 months .